Description
BSE circular regarding the listing of equity shares of Mahamaya Lifesciences Limited on the exchange.
Summary
BSE has announced the listing of equity shares of Mahamaya Lifesciences Limited on the exchange. This circular provides information about the newly listed securities.
Key Points
- Company Name: Mahamaya Lifesciences Limited
- Listing Date: November 17, 2025
- Security Type: Equity Shares
- Exchange: BSE (Bombay Stock Exchange)
Regulatory Changes
No regulatory changes announced in this circular.
Compliance Requirements
- The company must comply with all listing agreement requirements
- Regular disclosure and reporting obligations as per SEBI regulations
- Adherence to corporate governance norms
Important Dates
- Listing Date: November 17, 2025
- Circular Issue Date: November 17, 2025
Impact Assessment
The listing of Mahamaya Lifesciences Limited equity shares provides investors with a new investment opportunity in the lifesciences sector. The stock will now be available for trading on BSE, enhancing market depth and providing liquidity to existing shareholders.
Impact Justification
New equity listing on BSE - impacts trading availability for investors interested in Mahamaya Lifesciences Limited